We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Health

Researchers develop gene remedy that may goal airway and lungs by way of nasal spray

Last updated: May 23, 2025 6:21 am
Editorial Board Published May 23, 2025
Share
SHARE

Graphical summary. Credit score: Cell Stories Drugs (2025). DOI: 10.1016/j.xcrm.2025.102144

For gene remedy to work effectively, therapeutic molecules should be effectively delivered to the proper areas within the physique—a job generally given to adeno-associated viruses (AAV).

To enhance the AAV’s skill to ship therapeutics particularly to the lungs and airway, Mass Common Brigham researchers developed and utilized a brand new model, referred to as AAV.CPP.16, that may be administered with a nasal spray. In preclinical fashions, the modern device outperformed earlier variations by extra successfully focusing on the airway and lungs and exhibiting promise for respiratory and lung gene remedy. Outcomes are revealed in Cell Stories Drugs.

“We noticed that AAV.CPP.16, which we initially engineered to enter the central nervous system, also efficiently targeted lung cells,” stated senior writer FengFeng Bei, Ph.D., of the Division of Neurosurgery at Brigham and Girls’s Hospital. “This prompted us to further investigate AAV.CPP.16 for intranasal gene delivery to the respiratory airways.”

The researchers discovered AAV.CPP.16 outperformed earlier variations (AAV6 and AAV9) in cell tradition, mouse fashions, and non-human primate fashions. They then used the extra environment friendly device to ship scar-preventing gene remedy for pulmonary fibrosis, utilizing a mouse mannequin of the respiratory illness. Additionally they used the device to ship gene remedy for a viral an infection, the place the remedy prevented the replication of the SARS-CoV-2 virus in a mouse mannequin of COVID-19.

“Although further research is needed, our findings suggest that intranasal AAV.CPP.16 has strong translational potential as a promising delivery tool for targeting the airway and lung,” stated Bei.

Extra data:
Zhi Yang et al, Cross-species tropism of AAV.CPP.16 within the respiratory tract and its gene therapies in opposition to pulmonary fibrosis and viral an infection, Cell Stories Drugs (2025). DOI: 10.1016/j.xcrm.2025.102144

Supplied by
Mass Common Brigham

Quotation:
Researchers develop gene remedy that may goal airway and lungs by way of nasal spray (2025, Might 22)
retrieved 23 Might 2025
from https://medicalxpress.com/information/2025-05-gene-therapy-airway-lungs-nasal.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:airwaydevelopgeneLungsnasalResearchersspraytargettherapy
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Mind’s immune response linked to olfactory issues related to Alzheimer’s
Health

Mind’s immune response linked to olfactory issues related to Alzheimer’s

Editorial Board August 15, 2025
Amir Johnson Is More Than an Answer in N.B.A. Trivia
Day by day actions can form how righties vs. lefties course of visible enter
Could Inflation Prompt Powell to Act Like Volcker?
How Barnes & Noble Went From Villain to Hero

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?